Media Resources
Webinars
Take a look at our library of webinars or participate in our upcoming webinars. Mark your calendar now!
Navigating FDA
Navigating FDA:
Drug (and Biologic) Development Requirements
Device (and Diagnostic) Development Requirements
About the Event :
The basics of drug development are well known in many labs – but what happens when you have to shift from that general understanding to developing specific plans for your own project? What’s most important to think about? Where do you find information? When do you engage with FDA or a regulatory professional? During this talk you will learn how to find information to inform your specific development effort, and how to recognize when its time to call in the professionals.
Many types of medical devices, diagnostics, and digital health products must be reviewed by the FDA Center for Devices & Radiological Health (CDRH) before they hit the market. It can be daunting for innovators to determine which regulatory approach is applicable to their technology, and how to plan ahead for their interactions with FDA. In this webinar, an overview of the most common pre-market pathways will be provided, along with several key concepts. Attendees will gain a better understanding of where to start and where to find CDRH regulatory resources relevant for their own commercialization strategy.
Click HERE to learn more
Drug Repurposing Course: info on all sessions
Drug Repurposing Course:
SESSION 1:
IP STRATEGIES: CLAIMING NEW METHODS OF USE AND NEW FORMULATIONS, AND LICENSING IP
- Introduction to regulatory considerations for 505b2 application
- Intellectual Property (IP) considerations for drug repurposing
- Two mini case studies: new drug formulations vs new use
Presented by Gaby L. Longsworth, Ph.D., director, Sterne Kessler's Biotechnolgy & Chemical Practice Group, co-chair, Diversity Committee at Sterne Kessler, and LMG Life Sciences "Life Sciences Star", 2016-present.
SESSION 2:
COMMERCIALIZING ACADEMIC REPURPOSING DISCOVERIES: THE TECH TRANSFER AND COMPANY PERSPECTIVES
- Working with the inventor/PI
- Patenting and other exclusivity issues
- Collaboration and negotiations
- Due diligence issues
- Contracting, goals and reporting
- Relationship Management
- Confidentiality and other disclosures issues
Presented by Raja Krishnan, commercialization manager, University of Kentucky Office of Technology Commercialization, and Bruce Bloom, chief innovation officer, Healx. Raja Krishnan will provide an introduction and conclusion.
SESSION 3:
FDA: 505B2 APPLICATIONS AND POSITIONING STRATEGY
DATE: Thursday, February 25, 2021
TIME: 11:00 a.m. - 12:00 p.m. ET
- Regulatory considerations for drug repurposing
- Mini-case studies
Presented by Ken Phelps, president and founder, Camargo.
SESSION 4:
FUNDING OPPORTUNITIES: A NON-PROFIT FOUNDATION
DATE: Thursday, March 11, 2021
TIME: 11:00 a.m. - 12:30 p.m. ET
- Drugs that have been repurposed successfully and gotten FDA approval
- Clinical trials of repurposed drugs
- Case study of success story through non-profit foundation funding program
Presented by Barbara Goodman, president and CEO of Cures Within Reach, and/or Clare Thibodeaux, Ph.D., director of Scientific Affairs, Cures Within Reach, and TBD.
REGISTRATION COMING SOON
SESSION 5:
INDUSTRY EXPERT PANEL
DATE: Thursday, April 29, 2021
TIME: 11:00 a.m. - 12:30 p.m. ET
- Moderator-led discussion with industry and regulatory experts on drug repurposing
- Opportunity for audience to ask the experts questions
Panelists: Kristen Gullo, vice president of Development and Regulatory Affairs, US World Meds, Bruce Bloom, chief innovation officer, Healx, Douglas Balogh, director of Life Sciences, Guidehouse and TBD. Moderator: Raja Krishnan, commercialization manager, University of Kentucky Office of Technology Commercialization.
REGISTRATION COMING SOON
Regulatory Pathways for Phase I SBIR Companies
Tech Transfer 101 Series
Tech Transfer 101 is a 3-part webinar series for university administrators with a small or unestablished Technology Transfer Office (TTO) in the Southeast IDeA-Region (AR, KY, LA, MS, PR, SC, WV). The series addresses best practices for accelerating tech transfer and commercialization without a fully resourced office.
Focus:
Session #1: Bare minimum services and recommended initiatives for building a successful Tech Transfer Program
Session #2: Strategies for engaging with Faculty
Session #3: Strategies for engaging companies with researchers and entrepreneurs
EnRICH Q&A Sessions
EnRICH is a human health-focused innovation harvesting and commercialization “pre-accelerator” program for faculty and student innovators at Historically Black Colleges and Universities (HBCUs). We conducted two Q7A sessions to answer your questions. You can find the recordings of these sessions here.
Idea to Impact: The Translation and Commercialization of
Academic Research
Join Fast Forward Medical Innovation for a series of live, á la carte WEBINARS intended to educate and connect life science researchers and academic innovators interested in the commercialization of academic research. The series will outline the significance and critical milestones of developing novel therapeutics, medical devices, diagnostics, and digital health innovations, as well as essential collaborations with industry partners to translate a research-based idea into a product of impact.
UK OTC Series
Patent 101
Click HERE to listen to the webinar.
Pitching Your Research
Click HERE to listen to the webinar.
Everything You Need to Know About Agreements
Click HERE to listen to the webinar.
How Does OTC Market Technology?
Click HERE to listen to the webinar.
Pitching Your Research
Click HERE to listen to the webinar.
KYNETIC Series
Translational Training for Life Science Innovators
The Translational Training Series for Life Science Innovators was developed to help train innovators regarding the unique commercialization aspects in the healthcare industry. For the first time, these videos are being delivered virtually!
There is a library of videos to help you as you consider strategies to translate technologies out of your lab and into the marketplace.